hrcak mascot   Srce   HID

Izvorni znanstveni članak

Bone mineral content in patients with myasthenia gravis treated with cortisone

M. Harmut ; Institute for Medical Research and Occupational Health, Zagreb, Croatia
V. Kušec ; Institute for Medical Research and Occupational Health, Zagreb, Croatia
I. Matulić-Bedenić ; Faculty of Machine Engineering and Shipbuilding, Zagreb, Croatia
A. Jušić ; Centre for Neuromuscular Diseases, Medical Faculty, Zagreb, Croatia

Puni tekst: engleski, pdf (3 MB) str. 359-363 preuzimanja: 69* citiraj
APA 6th Edition
Harmut, M., Kušec, V., Matulić-Bedenić, I. i Jušić, A. (1988). Bone mineral content in patients with myasthenia gravis treated with cortisone. Arhiv za higijenu rada i toksikologiju, 39 (4), 359-363. Preuzeto s https://hrcak.srce.hr/152470
MLA 8th Edition
Harmut, M., et al. "Bone mineral content in patients with myasthenia gravis treated with cortisone." Arhiv za higijenu rada i toksikologiju, vol. 39, br. 4, 1988, str. 359-363. https://hrcak.srce.hr/152470. Citirano 18.06.2019.
Chicago 17th Edition
Harmut, M., V. Kušec, I. Matulić-Bedenić i A. Jušić. "Bone mineral content in patients with myasthenia gravis treated with cortisone." Arhiv za higijenu rada i toksikologiju 39, br. 4 (1988): 359-363. https://hrcak.srce.hr/152470
Harvard
Harmut, M., et al. (1988). 'Bone mineral content in patients with myasthenia gravis treated with cortisone', Arhiv za higijenu rada i toksikologiju, 39(4), str. 359-363. Preuzeto s: https://hrcak.srce.hr/152470 (Datum pristupa: 18.06.2019.)
Vancouver
Harmut M, Kušec V, Matulić-Bedenić I, Jušić A. Bone mineral content in patients with myasthenia gravis treated with cortisone. Arh Hig Rada Toksikol. [Internet]. 1988 [pristupljeno 18.06.2019.];39(4):359-363. Dostupno na: https://hrcak.srce.hr/152470
IEEE
M. Harmut, V. Kušec, I. Matulić-Bedenić i A. Jušić, "Bone mineral content in patients with myasthenia gravis treated with cortisone", Arhiv za higijenu rada i toksikologiju, vol.39, br. 4, str. 359-363, 1988. [Online]. Dostupno na: https://hrcak.srce.hr/152470. [Citirano: 18.06.2019.]

Sažetak
Bone mineral content (BMC) was measured in 23 patients with myasthenia gravis using the 241Am gamma ray attenuation method. Measurements were performed in the proximal (BMC6) and distal (BMC1) parts of the forearm, i.e. at 6 and 1 cm distance from the styloid process of the ulna in supine position. At 6 cm from the styloid process the bone is mostly compact, whereas at 1 cm distance it is mostly trabecular. The results were compared with the BMC values in age and sex matched controls. No signs of major bone loss were noticed in any of the myasthenic patients examined in spite of prolonged administration of fluorocortolone.

Hrčak ID: 152470

URI
https://hrcak.srce.hr/152470

[hrvatski]

Posjeta: 159 *